Laboratory Centrifuges Market - Integration of Automation & Advanced Features

 Overview:

The study involved four major activities to estimate the current size of the laboratory centrifuges market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Expected Revenue Surge:

The laboratory centrifuges market is projected to reach USD 2.2 billion by 2026 from USD 1.8 billion in 2021, at a CAGR of 4.0% from 2021 to 2026.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197749088

Major Growth Boosting Factors:

The growth of this market is driven by increasing R&D investments and research grants; rising technological advancements and innovative rotor designs; increasing prevalence of infectious diseases leading to a higher volume of sample testing & cell-based research in laboratory centrifuges; and widening applications of laboratory centrifuges.

Research Methodologies Followed:

Secondary Research:

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for this study.

Primary Research:

Several stakeholders such as laboratory centrifuges products manufacturers, vendors, distributors, and technologists from hospitals and clinics were consulted for this report. The demand side of this market is characterized by the increasing R&D investments and research grants; rising technological advancements and innovative rotor designs; increasing prevalence of infectious diseases leading to a higher volume of sample testing & cell-based research in laboratory centrifuges; and widening applications of laboratory centrifuges. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information.

“Hospitals are expected to hold the largest share of the laboratory centrifuges market, by end user in 2021.”

Based on end user, the laboratory centrifuges market is segmented into hospitals, biotechnology & pharmaceutical companies, and academic & research institutes. The hospitals segment accounted for the largest share in the laboratory centrifuges market in 2020. The increasing prevalence of diseases, coupled with the growing awareness regarding early diagnosis & treatment, increasing demand for blood, availability of novel and technologically advanced centrifuges for blood separation, and growing number of hospitals, especially in emerging countries, are some of the key factors driving the growth of the laboratory centrifuges market for hospitals.

“North America commanded the largest share of the laboratory centrifuges market in 2021.”

Based on region, the laboratory centrifuges market is segmented into North America, Europe, Asia Pacific, and Rest of the World (RoW). In 2020, North America commanded the largest share of the laboratory centrifuges market. The large share of North America can be attributed to the rising R&D investments by government bodies, increasing emphasis on better management and the treatment of infectious diseases, and rapid growth in the pharmaceutical industry.

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=197749088

Key Players:

The major players operating in this market are Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), and Eppendorf AG (Germany), KUBOTA Corporation (Japan), Sigma Laborzentrifugen GmbH (Germany), NuAire (US), Sartorius AG (Germany), Andreas Hettich GmbH & Co.KG (Germany), HERMLE Labortechnik GmbH (Germany), Cardinal Health (US), Agilent Technologies (US), Centurion Scientific (UK), QIAGEN N.V. (Netherlands), and Bio-Rad Laboratories, Inc. (US).

Laboratory Centrifuges Market worth $2.2 billion by 2026

 Overview of This Study:

The study involved four major activities to estimate the current size of the Laboratory Centrifuges Market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for this study.

Primary Research

Several stakeholders such as laboratory centrifuges products manufacturers, vendors, distributors, and technologists from hospitals and clinics were consulted for this report. The demand side of this market is characterized by the increasing R&D investments and research grants; rising technological advancements and innovative rotor designs; increasing prevalence of infectious diseases leading to a higher volume of sample testing & cell-based research in laboratory centrifuges; and widening applications of laboratory centrifuges. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197749088

Projected Growth in Revenue:

The laboratory centrifuges market is projected to reach USD 2.2 billion by 2026 from USD 1.8 billion in 2021, at a CAGR of 4.0% from 2021 to 2026. 

Growth Boosting Factors:

Increasing R&D investments and research grants; rising technological advancements and innovative rotor designs; increasing prevalence of infectious diseases leading to a higher volume of sample testing & cell-based research in laboratory centrifuges; and widening applications of laboratory centrifuges.

“Hospitals are expected to hold the largest share of the laboratory centrifuges market, by end user in 2021.”

Based on end user, the laboratory centrifuges market is segmented into hospitals, biotechnology & pharmaceutical companies, and academic & research institutes. The hospitals segment accounted for the largest share in the laboratory centrifuges market in 2020. The increasing prevalence of diseases, coupled with the growing awareness regarding early diagnosis & treatment, increasing demand for blood, availability of novel and technologically advanced centrifuges for blood separation, and growing number of hospitals, especially in emerging countries, are some of the key factors driving the growth of the laboratory centrifuges market for hospitals.

“North America commanded the largest share of the laboratory centrifuges market in 2021.”

Based on region, the laboratory centrifuges market is segmented into North America, Europe, Asia Pacific, and Rest of the World (RoW). In 2020, North America commanded the largest share of the laboratory centrifuges market. The large share of North America can be attributed to the rising R&D investments by government bodies, increasing emphasis on better management and the treatment of infectious diseases, and rapid growth in the pharmaceutical industry.

Key Developments:

# In 2021, Eppendorf AG launched the Multipurpose Centrifuge 5910 Ri, which offers advanced features to enhance and simplify the process of centrifugation.

# In 2021, Sartorius announced to expand its presence in Michigan. Sartorius will open a new 130,000-square-foot (12,000-square-meter) state-of-the-art plant in Ann Arbor in late 2023. The new facility would focus on consolidating the existing business operations in Washtenaw County to create a center of excellence in Ann Arbor for the Laboratory and Bioprocess Products and Services in North America.

# In 2020, Eppendorf AG launched a refrigerated 24-place centrifuge 5425 R, which offers protection to temperature-sensitive samples and offers immediate cooldown of temperature 8 minutes (21° C to 4°C); these centrifuges come with six rotors.

# In 2020, Eppendorf expanded its production of centrifuges in Leipzig, Germany.

# In 2019, Thermo Fisher Scientific acquired, within the Laboratory Products and Services segment, Brammer Bio for approximately USD 1.67 billion in cash. Brammer Bio is a leading viral vector contract development and manufacturing organization for gene and cell therapies. The acquisition expanded the segment’s contract manufacturing capabilities. Brammer Bio reported revenues of approximately USD 140 million in 2018.

# In 2018, Andreas Hettich GmbH & Co.KG launched its dual centrifuge ZentriMix 380 R, which facilitates numerous routine tasks of the research and analytical laboratories.

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=197749088

Laboratory Centrifuges Market worth $2.2 billion by 2026

 Overview of This Study:

The study involved four major activities to estimate the current size of the laboratory centrifuges market. Exhaustive secondary research was done to collect information on the market and its different subsegments.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Download PDF Brochure@ 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197749088

Research Methodologies Followed for This Study:

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for this study.

Primary Research

Several stakeholders such as laboratory centrifuges products manufacturers, vendors, distributors, and technologists from hospitals and clinics were consulted for this report. The demand side of this market is characterized by the increasing R&D investments and research grants; rising technological advancements and innovative rotor designs; increasing prevalence of infectious diseases leading to a higher volume of sample testing & cell-based research in laboratory centrifuges; and widening applications of laboratory centrifuges. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the laboratory centrifuges market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

# The key players in the industry and markets have been identified through extensive secondary research.

# The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.

# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the laboratory centrifuges industry.

Expected Growth in Revenue Generation:

The laboratory centrifuges market is projected to reach USD 2.2 billion by 2026 from USD 1.8 billion in 2021, at a CAGR of 4.0% from 2021 to 2026. 

Growth Boosting Factors:

Increasing R&D investments and research grants; rising technological advancements and innovative rotor designs; increasing prevalence of infectious diseases leading to a higher volume of sample testing & cell-based research in laboratory centrifuges; and widening applications of laboratory centrifuges.

Request Sample Pages@ 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=197749088

RESTRAINTS: High equipment costs

Centrifuges are expensive instruments and require significant expenditure post-purchase for regular—and crucial—maintenance. The high cost of these instruments can be attributed to their complex design, rotors, and microprocessors. In this market, ultracentrifuges are among the most expensive equipment. Their rotors alone can cost upwards of USD 5,000 to 7,000, and benchtop rotors and floor standing rotors can cost around USD 30,000 to 55,000.

Moreover, various accessories such as tubes for high-speed centrifuges are very expensive, and small scratches or cracks can render them unusable and need replacement. The high price of these centrifuges may hinder the growth of this market.

OPPORTUNITY: Integration of automation and advanced features in laboratory centrifuges

The integration of automation and robotics into laboratory centrifuges is expected to create more opportunities in the future. There is a considerable amount of research for the development of autonomous/robotic centrifuges. Some companies offer advanced centrifuges that can serve during hostile and challenging pandemic situations or handling hazardous biological samples. These centrifuges can be essential equipment into a biological or life sciences lab for research purposes and clinical labs for mass scale processing of the biohazardous sample for a massive scale diagnosis.

The automation of laboratory instruments is a new trend, and this space includes the automation of laboratory centrifuges. For instance, Zinsser NA Inc. (US) offers automated centrifugation dedicated to robotic applications and requires two main features integrated into its Zinsser liquid handling platforms. These centrifuges offer remote-controlled doors and access to position the lids. The centrifuge offers the rotor in a precise position, allowing the robot gripper to access the labware in the rotor. Such automation eliminates manual intervention and provides more reliable and reproducible processes while handling biohazardous samples.

End Users:

“Hospitals are expected to hold the largest share of the laboratory centrifuges market, by end user in 2021.”

Based on end user, the laboratory centrifuges market is segmented into hospitals, biotechnology & pharmaceutical companies, and academic & research institutes. The hospitals segment accounted for the largest share in the laboratory centrifuges market in 2020. The increasing prevalence of diseases, coupled with the growing awareness regarding early diagnosis & treatment, increasing demand for blood, availability of novel and technologically advanced centrifuges for blood separation, and growing number of hospitals, especially in emerging countries, are some of the key factors driving the growth of the laboratory centrifuges market for hospitals.

Geographical Growth Scenario:

“North America commanded the largest share of the laboratory centrifuges market in 2021.”

Based on region, the laboratory centrifuges market is segmented into North America, Europe, Asia Pacific, and Rest of the World (RoW). In 2020, North America commanded the largest share of the laboratory centrifuges market. The large share of North America can be attributed to the rising R&D investments by government bodies, increasing emphasis on better management and the treatment of infectious diseases, and rapid growth in the pharmaceutical industry.

Speak to the Analyst@ 

https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=197749088

Laboratory Centrifuge Market - Global Leaders and Growth Strategies Adopted by Them

The laboratory centrifuges market is expected to reach USD 1.2 billion by 2023 from USD 1.1 billion in 2018, at a CAGR of 2.8%. Market growth is primarily driven by factors such as technological advancements, increasing research, and a high prevalence of target diseases.

However, the market faces major challenges in the form of mechanical failure of equipment (caused due to improper maintenance of rotors) and the release of harmful chemicals in the centrifugation of certain substances. The low replacement value of centrifuges (due to their long lifespans) may hinder market growth.

The research methodology used to estimate the market size includes the following:

# The key players in the industry and markets have been identified through extensive secondary research.

# Laboratory centrifuges revenue generated by the leading players have been determined through primary and secondary research processes.

# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197749088

The laboratory centrifuges market has several big players. Key players in the market include Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Eppendorf AG (Germany), Sigma Laborzentrifugen GmbH (Germany), Andreas Hettich GmbH & Co. KG (Germany), Kubota Corporation (Japan), Koki Holdings Co., Ltd. (Japan) (previously Hitachi Koki Co., Ltd.), QIAGEN N.V. (Netherlands), NuAire (US), Sartorius (Germany), HERMLE Labortechnik GmbH (Germany), and Becton, Dickinson and Company (US).

These players have adopted various growth strategies, such as partnerships, agreements, and collaborations; and new product launches, to further expand their presence in the laboratory centrifuges market.

Product launches have been the key growth strategies adopted players from 2016 to 2018, which helped them to innovate on their offerings and broaden their customer base. Some of the leading players who adopted this strategy include Thermo Fisher Scientific Inc. (US), Eppendorf AG (Germany), and Danaher Corporation (US).

Recent Industry Developments:

# In 2016, Thermo Fisher Scientific launched Medifuge

# In 2016, Beckman Coulter partnered with Henry Ford Health System. This partnership aimed to enhance and streamline operations by fully automating the Henry Ford Hospital laboratory and modernizing the equipment at 12 other Henry Ford locations.

# In 2018, Eppendorf launched Centrifuge 5425

Thermo Fisher Scientific Inc. is one of the leading players in laboratory centrifuges market. The company’s strong brand recognition and extensive product portfolio in the laboratory centrifuges market is its key strength. To maintain a leading position in the market, Thermo Fisher has adopted product launches as its key organic growth strategy. Thermo Fisher has a robust promotional strategy in place and participates in various trade exhibitions, seminars, and workshops to promote its products. It is also supported by a strong sales force in over 180 countries.

Key Questions addressed by the report:

# Where will all these developments take the industry in the mid to long term?

# Which are the key players in the market and how intense is the competition?

# Which are the recent contracts and agreements key players have signed?

Request Sample Pages@ 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=197749088

Eppendorf AG is one of the key players in the laboratory centrifuges market. The company’s leading position in the market can be attributed to its focus on product innovation. The company focuses on the development of its R&D capabilities, core competence, and on meeting customer and market demands.

This has allowed Eppendorf to introduce innovative products in the market. In the last two years, the company launched Centrifuge 5425, 5910 R, and refrigerated centrifuge 5920 R. This strengthened the company’s product portfolio and helped it to maintain its position in the market. The company has a strong presence across Europe, the Americas, APAC, and Africa. In 2018, the company launched Centrifuge 5425, 5910 R. This strengthened the company’s product portfolio and helped it to maintain its position in the market.